Skip to main content

Table 1 Antibiotics susceptibility profile for selected Gram-negative bacteria as read in mean diameter of zones of inhibition (mm) after exposure to acoustic treatment at 5000 Hz/90 dB compared with control

From: Evaluation of the effects of sound exposure and low field electromagnetism on growth and antibiotics susceptibility of some microorganisms

Bacteria CAZ CIP TET IMP AMP
S. marcescens ATCC14756 a) 26 ± 1.4*
b) 17 ± 0
c) 25 ± 1.4
d) 26 ± 1.4
a) 28 ± 2.8
b) 30 ± 0.7
c) 28 ± 2.1
d) 31 ± 1.4
a) R
b) R
c) R
d) R
a) 26 ± 1.4
b) 19 ± 2.1
c) 24 ± 1.4
d) 25 ± 0.7
a) R
b) R
c) R
d) R
P. aeruginosa ATCC9027 a) 26 ± 1.4
b) 23 ± 0.7
c) 20 ± 1.4
d) 22 ± 0
a) 34 ± 3.5
b) 29 ± 1.4
c) 21 ± 0.7
d) 22 ± 3.5
a) R
b) R
c) R
d) R
a) 26 ± 1.4
b) 28 ± 2.1
c) 24 ± 0.7
d) 29 ± 1.4
a) R
b) R
c) R
d) 11 ± 1.4
G. oxydans ATCC19357 a) 27 ± 2.8
b) R
c) 29 ± 1.4
d) 19 ± 4.9
a) 26 ± 0.7
b) 27 ± 3.5
c) 21 ± 2.1
d) 21 ± 0.7
a) R
b) 17 ± 2.8
c) 12 ± 0.7
d) R
a) 26 ± 1.4
b) 27 ± 2.8
c) 24 ± 2.8
d) 28 ± 0.7
a) 23 ± 0.7
b) 28 ± 0.7
c) 14 ± 2.1
d) R
R. sphaeroides ATCC17023 a) 24 ± 0.7
b) 16 ± 0
c) R
d) 14 ± 5.7
a) 24 ± 0.7
b) 15 ± 0
c) 20 ± 2.1
d) 18 ± 2.1
a) R
b) R
c) 25 ± 0.7
d) R
a) R
b) 19 ± 0.7
c) 21 ± 0.7
d) 23 ± 5.7
a) R
b) R
c) R
d) R
C. freundii ATCC33128 a) 14 ± 0.7
b) 31 ± 6.4
c) 16 ± 4.2
d) 14 ± 2.1
a) 26 ± 0.7
b) 22 ± 5.7
c) 16 ± 2.1
d) 19 ± 7.1
a) 25 ± 0
b) 12 ± 2.8
c) 15 ± 2.1
d) 20 ± 2.1
a) 29 ± 4.2
b) 30 ± 0.7
c) 28 ± 2.1
d) 32 ± 0.7
a) 30 ± 2.1
b) 21 ± 9.2
c) R
d) R
Y. pestis ATCC11953 a) 13 ± 1.4
b) 13 ± 2.1
c) 15 ± 0.7
d) 13 ± 1.4
a) 25 ± 0
b) 20 ± 0.7
c) 22 ± 0.7
d) 21 ± 0.7
a) R
b) R
c) R
d) R
a) 23 ± 1.4
b) 18 ± 5.7
c) 24 ± 1.4
d) 25 ± 0
a) 15 ± 0
b) R
c) 13 ± 0.7
d) 21 ± 2.1
K. pneumoniae ATCC25923 a) 26 ± 1.4
b) 26 ± 0
c) 26 ± 1.4
d) 28 ± 5.7
a) 31 ± 2.1
b) 20 ± 1.4
c) 23 ± 3.5
d) 18 ± 1.4
a) R
b) 16 ± 12.7
c) 17 ± 4.2
d) R
a) 22 ± 2.8
b) R
c) 25 ± 4.9
d) 31 ± 1.4
a) 24 ± 0.7
b) 21 ± 1.4
c) 14 ± 6.4
d) R
A. aceti ATCC15973 a) 19 ± 4.2
b) 21 ± 2.8
c) 23 ± 2.8
d) 27 ± 1.4
a) 21 ± 9.9
b) 19 ± 1.4
c) 19 ± 0
d) 21 ± 2.8
a) 13 ± 4.2
b) 15 ± 9.2
c) 13 ± 1.4
d) 17 ± 0.7
a) 17 ± 1.4
b) 30 ± 2.4
c) 26 ± 0.7
d) 28 ± 0
a) 16 ± 4.2
b) R
c) R
d) R
E. coli ATCC25922 a) 29 ± 1.4
b) 20 ± 1.4
c) R
d) 15 ± 1.4
a) 22 ± 1.4
b) 21 ± 0.7
c) 18 ± 3.5
d) 24 ± 0.7
a) 19 ± 0
b) R
c) 14 ± 7.8
d) R
a) 33 ± 4.2
b) 30 ± 0.7
c) 30 ± 2.1
d) 29 ± 1.4
a) 26 ± 1.4
b) R
c) R
d) R
  1. a) Control b) 24 h c) 48 h d) 72 h R—Resistance CAZ—Ceftazidime CIP—Ciprofloxacin
  2. TET—Tetracycline IMP—Imipenem AMP—Ampicillin *Data are mean of replicate ± Standard deviation